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6 Literature review of human health effects 
Existing LCA methods define PM in very general terms (i.e., total mass of PM). However, 
this evaluation of PM neglects the highly complex nature and variable health impacts of 
PM. This literature search aims to develop a more refined description of PM in LCAs that 
better reflects the contribution of PM to adverse effects than does mass alone. The 
purpose of the literature review described herein is to identify characteristics of PM that 
are associated with human health effects in epidemiology studies and that can be 
incorporated into the LCA methodology. 
6.1 A short introduction into odds ratio and relative risk 
The relation between particle concentration and health effect is described with relative 
risks (RR) or odds ratios (OR)29. In statistics and mathematical epidemiology, RR is the 
risk of an event (or of developing a disease) relative to exposure. Relative risk is a ratio of 
the probability of the event occurring in the exposed group versus a non-exposed (less 
exposed) group. A RR of 1 means there is no difference in risk between the two groups. 
An RR of > 1 means the event is more likely to occur in the experimental group than in the 
control group. As long as the OR is around 1, there is more or less no difference between 
of RR and OR. When OR is more than 2.5 or less than 0.5 or probability of outcome in the 
unexposed group is more than 0.1 (10%), a correction should be applied30, 31. In this study, 
values of OR higher than 1.1 and smaller 0.97 were discarded. Thus, in order to simplify 
the reading of this report all estimates of association with RR and OR are presented as RR 
only but it is referred to both, RR and OR. 
Mean values of RR can be analysed with paired t-test in order to get an answer to the risk 
differences between the two compared substances. Paired sample t-tests analysis over 
the 95% CI (of each data-point provided in the literature studies) provides insight into the 
explained variance of the compared substances. The hypothesis is that the CI for each 
size class is smaller than CI for PM10. This would support that the variance for the health 
outcomes is smaller when PM is split in different size classes. 
Power analysis can be used to calculate the minimum sample size required so that it is 
reasonably likely to detect an effect of a given size32, 33. Required sample size was 
calculated for a better interpretation of the analysed results from literature search. The 
sample size calculation was performed with an online power analysis tool34 using a Power 
of 0.8 and a significance level α of 0.05. 
6.2 Literature review of epidemiology studies on the association between exposure 
to particulate matter and human health outcomes 
Katherine Clark, Michael Riediker of IST, Lausanne 
Dominic Notter, Hans-Joerg Althaus of EMPA, Dübendorf 
Background 
Airborne particles can come from a variety of sources and contain variable chemical 
constituents. Some particles are formed by natural processes, such as volcanoes, erosion, 
sea spray, and forest fires, while other are formed by anthropogenic processes, such as 
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industrial- and motor vehicle-related combustion, road-related wear, and mining. In 
general, larger particles (those greater than 2.5 µm) are formed by mechanical processes, 
while those less than 2.5 µm are formed by combustion processes. The chemical 
composition of particles is highly influenced by the source: for combustion-related 
particles, factors such as temperature of combustion, fuel type, and presence of oxygen or 
other gases can also have a large impact on PM composition. These differences can often 
be observed at a regional level, such as the greater sulphate-composition of PM in regions 
that burn coal for electricity production (which contains sulphur) versus regions that do 
not35. 
Most countries maintain air monitoring networks, and studies based on the resulting data 
are the most common basis for epidemiology studies on the health effects of PM. Data 
from these monitoring stations can be used to evaluate the relationship between 
community-level exposure to ambient particles and health outcomes (i.e., morbidity or 
mortality from various causes). Respiratory and cardiovascular outcomes are the most 
commonly assessed, although studies have also considered other related specific 
outcomes such as diabetes and congenital heart disease. 
The data on particle characteristics is usually not very detailed and most often includes 
some combination of PM2.5, PM10, sulphate, and NO2. Other descriptors that are less 
commonly found include particle number (ultrafine particles), metal components of PM, 
local traffic intensity, and EC/OC. Measures of association are usually reported per 10 
µg/m3 or interquartile range increase in pollutant concentration. As the exposure data are 
taken from regional monitoring stations, the measurements are not representative of an 
individual’s exposure. 
Particle size is an important descriptor for understanding where in the human respiratory 
system the particles will deposit: as a general rule, smaller particles penetrate to deeper 
regions of the lungs. Initial studies on the health effects of particulate matter focused on 
mass of the particles, including either all particles (often termed total suspended 
particulate or TSP) or PM10 (all particles with an aerodynamic diameter less than 10 µm). 
More recently, studies have considered both PM10 and PM2.5, with the latter corresponding 
more directly to combustion-related processes. UFPs are a dominant source of particles in 
terms of PNC, yet are negligible in terms of mass. Very few epidemiology studies have 
measured the effect of UFPs on health; however, the numbers of studies on this topic are 
increasing. In addition to size, chemical composition is of importance when understanding 
the toxicity of particles. Some studies consider the composition of particles in addition to 
mass; however this is not common, in part due the cost and labour involved in such 
analyses. 
Methods 
A literature review was conducted with the aims of identifying particle characteristics in 
addition to total mass that can be used to distinguish particle health effects. The literature 
on particle health effects is vast, and therefore a systematic review was not possible. 
Rather, priority was given to studies that: 
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 Were papers or reports of consensus opinions. 
 Have had a significant impact on the understanding of human health effects or 
particles. 
 Included a detailed analysis of particle composition or properties. 
 Addressed specific sources of particles (i.e., source apportionment studies or 
studies of acute events [volcanoes, forest fires]). 
Toxicology studies were not included. Although such studies play an important role in 
identifying mode of action and pre-clinical effects, limited efforts were focused on the most 
human-relevant data. 
Results 
Mass of PM2.5 and PM10: 
Mass-based measurements of particles are the most commonly-used measures in 
epidemiology studies on the effect or particulate matter on health. These measures are 
most easily and commonly collected, providing a large dataset for conducting such 
studies. For example, a quick search in PubMed using the search terms ‘epidemiology’, 
‘particulate’, and ‘matter’ yields over 7000 hits. A review of all of the literature in this field is 
not feasible, but targeted reviews of existing health assessments of PM are informative. 
The United States Environmental Protection Agency (US EPA) has undertaken perhaps 
the most thorough assessment of the health effects of particulate matter in their Integrated 
Scientific Assessment for Particulate Matter36. The purpose of this assessment is to 
support US air quality regulations. This document, of which the most recent 2009 version 
numbers over 2000 pages, evaluates the existing knowledge available to estimate the 
effect of PM on human and environmental health, and includes studies on toxicology, 
epidemiology, controlled human exposure, atmospheric science, and other disciplines. 
This document provides a detailed analysis of the effects of PM2.5 and PM10 in particular, 
however is primarily focused on data relevant to the United States. The sections on 
epidemiology studies include reviews of hundreds of epidemiology studies, and the 
conclusions based on these reviews are summarized below. 
The EPA ISA states the following regarding the effects of long and short term exposure to 
PM2.5 and PM10. For more details on any individual effect, refer to the source page within 
the document. 
1. Short term effects of PM2.5 
Regarding cardiovascular effects of short term exposure to PM2.5 
“Epidemiologic studies that examined the effect of PM2.5 on cardiovascular 
emergency department (ED) visits and hospital admissions reported consistent 
positive associations (predominantly for ischemic heart disease [IHD] and congestive 
heart failure [CHF]), with the majority of studies reporting increases ranging from 0.5 
to 3.4% per 10 μg/m3 increase in PM2.5. These effects were observed in study 
locations with mean 24-h average PM2.5 concentrations ranging from 7-18 μg/m3 
(Section 6.2.10)”. (p. 2-9) 
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“The multicity studies evaluated reported consistent increases in cardiovascular 
mortality ranging from 0.47 to 0.85% in study locations with mean 24-h average PM2.5 
concentrations above 12.8 μg/m3 (Table 6-15)”. (p. 2-9) 
Regarding respiratory effects of short term exposure to PM2.5 
“Most studies reported effects in the range of ~1% to 4% increase in respiratory 
hospital admissions and ED visits and were observed in study locations with mean 
24-h average PM2.5 concentrations ranging from 6.1-22 μg/m3.” (p. 2-10) 
“The multicity studies evaluated reported consistent, precise increases in respiratory 
mortality ranging from 1.67 to 2.20% in study locations with mean 24-h average PM2.5 
concentrations above 12.8 μg/m3 (Table 6-15)”. (p. 2-10) 
Regarding all cause mortality effects of short term exposure to PM2.5 
“The evaluation of multicity studies found that consistent and precise risk estimates 
for all-cause (nonaccidental) mortality that ranged from 0.29 to 1.21% per 10 μg/m3 
December 2009 2-10 increase in PM2.5 at lags of 1 and 0-1 days. In these study 
locations, mean 24-h average PM2.5 concentrations were 12.8 μg/m3 and above 
(Table 6-15)” (p. 2-11) 
2. Long term effects of PM2.5 
Regarding cardiovascular effects of long term exposure to PM2.5 
“Evidence from toxicological studies provides biological plausibility and coherence 
with studies of short-term exposure and cardiovascular morbidity and mortality, as 
well as with studies that examined long-term exposure to PM2.5 and cardiovascular 
mortality. Taken together, the evidence from epidemiologic and toxicological studies 
is sufficient to conclude that a causal relationship exists between long-term 
exposures to PM2.5 and cardiovascular effects.” (p. 2-12) 
Regarding respiratory effects of long term exposure to PM2.5 
“Recent epidemiologic studies conducted in the U.S. and abroad provide evidence of 
associations between long-term exposure to PM2.5 and decrements in lung function 
growth, increased respiratory symptoms, and asthma development in study locations 
with mean PM2.5 concentrations ranging from 13.8 to 30 μg/m3 during the study 
periods (Section 7.3.1.1 and Section 7.3.2.1)…. Collectively, the evidence from 
epidemiologic and toxicological studies is sufficient to conclude that a causal 
relationship is likely to exist between long-term exposures to PM and respiratory 
effects.” (p. 2-12) 
Regarding mortality effects of long term exposure to PM2.5 
“The evidence for cardiovascular and respiratory morbidity due to short- and long-
term exposure to PM2.5 provides biological plausibility for cardiovascular- and 
respiratory-related mortality. Collectively, the evidence is sufficient to conclude that a 
causal relationship exists between long-term exposures to PM2.5 and mortality.” (p. 2-
12). 
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Regarding reproductive and developmental effects of long term exposure to PM2.5 
“The epidemiologic literature does not consistently report associations between long-
term exposure to PM and preterm birth, growth restriction, birth defects or decreased 
sperm quality. Toxicological evidence supports an association between PM2.5 and 
PM10 exposure and adverse reproductive and developmental outcomes, but provide 
little mechanistic information or biological plausibility for an association between long-
term PM exposure and adverse birth outcomes (e.g., low birth weight or infant 
mortality). New evidence from animal toxicological studies on heritable mutations is 
of great interest, and warrants further investigation. Overall, the epidemiologic and 
toxicological evidence is suggestive of a causal relationship between long-term 
exposures to PM2.5 and reproductive and developmental outcomes.” (p. 2-13) 
Regarding cancer, mutagenicity, and genotoxicity effects of long term exposure to 
PM2.5 
“Collectively, the evidence from epidemiologic studies, primarily those of lung cancer 
mortality, along with the toxicological studies that show some evidence of the 
mutagenic and genotoxic effects of PM is suggestive of a causal relationship 
between long-term exposures to PM2.5 and cancer.” (p. 2-13) 
3. Short term effects of PM10-2.5 
Regarding cardiovascular effects of short term exposure to PM10-2.5 
“Generally positive associations were reported between short-term exposure to PM10-
2.5 and hospital admissions or ED visits for cardiovascular causes…. The PM10-2.5 
associations with cardiovascular hospital admissions and ED visits were observed in 
study locations with mean 24-h average PM10-2.5 concentrations ranging from 7.4 to 
13 μg/m3. These results are supported by the associations observed between PM10-
2.5 and cardiovascular mortality in areas with 24-h average PM10-2.5 concentrations 
ranging from 6.1-16.4 μg/m3 (Section 6.2.11).” (p. 2-17) 
Regarding respiratory effects of short term exposure to PM10-2.5 
“A number of recent epidemiologic studies conducted in Canada and France found 
consistent, positive associations between respiratory ED visits and hospital 
admissions and short-term exposure to PM10-2.5 in studies with mean 24-h average 
concentrations ranging from 5.6-16.2 μg/m3 (Section 6.3.8). In these studies, the 
strongest relationships were observed among children, with less consistent evidence 
for adults and older adults (i.e., ≥ 65 years). In a large multicity study of older adults, 
PM10-2.5 was positively associated with respiratory hospital admissions in both single 
and copollutant models with PM2.5. In addition, a U.S.-based multicity study found 
evidence for an increase in respiratory mortality upon short-term exposure to PM10-2.5, 
but these associations have not been consistently December 2009 2-18 observed in 
single-city studies (Section 6.3.9).” (p. 2-18) 
Regarding mortality effects of short term exposure to PM10-2.5 
“The majority of studies evaluated in this review provide some evidence for mortality 
associations with PM10-2.5 in areas with mean 24-h average concentrations ranging 
  
 
Human health damage characterisation factors for particulate matter emissions   30 
from 6.1-16.4 μg/m3. However, uncertainty surrounds the PM10-2.5 associations 
reported in the studies evaluated due to the different methods used to estimate PM10-
2.5 concentrations across studies (e.g., direct measurement of PM10-2.5 using 
dichotomous samplers, calculating the difference between PM10 and PM2.5 
concentrations). In addition, only a limited number of PM10-2.5 studies have 
investigated potential confounding by gaseous copollutants or the influence of model 
specification on PM10-2.5 risk estimates.” (p. 2-19) 
With regards to the shape of the concentration-response curve, most of the studies 
evaluated in the PM ISA supported the use of no threshold log-linear models. 
The World Health Organization (WHO) has developed Air Quality Guidelines (AQG) for 
ambient PM10 and PM2.5 37. These guidelines are primarily based on published analyses of 
the data from selected epidemiological studies of PM2.5 exposure, such as the Harvard 
Six-Cities study and the American Cancer Society study38-40. There are few large 
epidemiology studies of the effects of PM10-2.5, yet it may also be hazardous and is the 
more widely-used measure of ambient air pollution: therefore, the WHO PM10 issued 
guidelines for PM10 that are based on those for PM2.5, using a multiplier of 2. (In other 
words, the ratio of PM2.5 to PM10 is assumed to be 0.5). 
The WHO annual air quality guideline for PM2.5 is 10 µg/m3, a concentration which 
deciphers the lower range at which significant effects were observed in epidemiologic 
studies. Interim targets were also issued for countries that could not immediately meet the 
AQG, however these estimates are associated with higher long term mortality. Based on 
their mortality estimates associated with different PM2.5 levels, the WHO estimate a 6% 
increase in mortality per long term 10 µg/m3 increase in PM2.5 above 10 µg/m3 (and 
likewise 20 µg/m3 increase in PM10). 
The WHO also issued short term (24 hours) air quality guidelines for PM2.5 of 25 µg/m3, 
which were based on meta-analyses of data from the US and Europe, and found 
consistent with data from Asia. These were based on the assumption of a 0.5% increase in 
mortality per 10ug/m3 increase in daily PM10 concentration (and thus 5 µg/m3 increase in 
daily PM2.5 concentration)37. 
Brook, et al.41 (2010) published a second scientific statement of the American Heart 
Association regarding the association between particulate matter and cardiovascular 
disease. This statement was assembled by a multi-disciplinary group of particulate matter 
experts that reviewed the previous AHA statement and the evidence that had been 
published since that statement. The group reviewed and commented on evidence 
regarding mortality, morbidity, association with specific diseases, biological mechanisms, 
and susceptible groups. A summary of the statements regarding mortality and morbidity 
due to PM are presented here in Brook et al.41. 
With regards to time series analysis of short term exposure to PM, “The overall evidence 
from time-series analyses conducted worldwide since publication of the first AHA 
statement confirms the existence of a small, yet consistent association between increased 
mortality and short-term elevations in PM10 and PM2.5 approximately equal to a 0.4% to 
1.0% increase in daily mortality (and cardiovascular death specifically) due to a 10 µg/m3 
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elevation in PM2.5 during the preceding 1 to 5 days (Table 2).” (p. 2338) 
With regards to cohort studies on long term exposure to PM, “The overall evidence from 
the cohort studies demonstrates on average an approximate 10% increase in all-cause 
mortality per 10 µg/m3 elevation in long-term average PM2.5 exposure. The mortality risk 
specifically related to CVD appears to be elevated to a similar (or perhaps even greater) 
extent, ranging from 3% to 76% (Table 3). This broader estimated range in risk compared 
with the short-term effects observed in time series is due to several recent cohort studies 
that demonstrated larger cardiovascular mortality risks (e.g., >30%) than in earlier cohort 
observations. This may reflect superior aspects of these studies that allowed for a better 
characterization of the cardiovascular risk of long-term exposure, the fact that these 
cohorts consisted of only women, or other unclear reasons.” (p. 2341) 
With regards to exposure to PM and hospitalization: “Excess cardiovascular mortality and 
increased rates of hospitalizations are similarly associated with day-to-day changes in PM 
air pollution (Tables 2 and 4). However, significant differences between geographic 
regions in the risk relationships have been observed, and more investigation is required to 
explain this heterogeneity.” (p. 2343) 
Cooke et al.42 (2007) performed an expert elicitation with 6 European experts in 
epidemiology and exposure assessment to determine their views on the impact of PM2.5 on 
mortality. The experts were provided with background material, reports, and publications, 
and asked to estimate the effect of certain changes in PM2.5 concentration on mortality 
rates in various regions of the world. Overall, the results suggested that regulatory risk 
assessments underestimate the effect of PM2.5 on mortality. However, the effect estimates 
among the experts were quite variable.  
Roman et al.43 (2008) performed a similar expert elicitation on the impact of PM2.5 on 
mortality, however with 12 leading experts from the US. The experts generally estimated 
effects that were above those of the American Cancer Society study median of 0.6% per 
μg/m3 and below the original Six Cities median of 1.2% per μg/m3. As with the European 
experts, the experts generally estimated effects of PM2.5 and uncertainty in these estimates 
were generally higher than those in the EPA risk assessment for PM. 
Particle number concentration 
As particle size decreases, the mass of the particles becomes increasing negligible. 
Ultrafine particles are a dominant source of particles in terms of PNC, yet are negligible in 
terms of mass. Although thought to be potent in terms of human health effects, the 
presence of these particles is not well-accounted for in the mass-based assessments of 
PM2.5 or PM10. Recently, more studies have started assessing PNC in addition to mass in 
air pollution epidemiology studies.  
Hoek, et al.44 (2010) conducted an expert elicitation among toxicologists, epidemiologists, 
and clinicians that have well-established expertise in ultrafine particles. The purpose was 
to estimate the particle-response relationship and corresponding uncertainty for urban air 
pollution. The limited amount of information, particularly the lack of long-term studies and 
few studies on hospital admissions, contributed to uncertainty among the experts. Overall, 
the experts estimated a median (95% confidence interval (CI)) of 0.30% (0.10, 0.90%) 
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reduction in deaths associated with a 1,000 /cm3 decrease in UFP. For hospital 
admissions, the median estimates were 0.20% and 0.16% for cardiovascular and 
respiratory diseases, respectively (95% CI not reported). 
We identified and reviewed 11 studies that specifically considered the human health 
effects of PNC on health. About half of these studies considered UFP specifically, whereas 
others considered PNC, which was typically not further defined. Based on the 
instrumentation used to make PNC measurements, the size ranges included in this metric 
were likely on the order of 20 to 1,000 nm. Overall, these studies support the findings of 
the expert group gathered by Hoek, et al. and suggest an increased risk of adverse 
cardiovascular and respiratory outcomes for increasing PNC (UFP and PNC). A summary 
of the results for CVD and respiratory outcomes are shown in Figures 9 and 10, 
respectively. Based upon the studies reviewed here, the expert elicitation estimate of 0.3% 
reduction in deaths per 1,000 particles/cm3 seems plausible. 
 
Figure 9. Estimates of association with 95% confidence interval for PNC on cardiovascular outcomes. 
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Figure 10. Estimates of association with 95% confidence interval for PNC on respiratory outcomes. 
Andersen et al.45 (2008) measured health effect in terms of respiratory or CVD hospital 
admissions by size and number concentration. The total number concentration (NC) was 
not statistically significant. Authors used interquartile ranges (IQR) for modelling 
(3907/cm3). 
Andersen et al.46 (2010) considered effects of UFP and PM10 on incidence of stroke. 
Several types of stroke were considered, and the association was strongest (and most 
significant) for mild ischaemic stroke without atrial fibrillation (odds ratio, OR =1.21). OR do 
not show high associations when considering all ischaemic or haemorrhagic strokes in 
general. Effects measured per IQR change in UFP (3918 /cm3). 
Atkinson et al.47 (2010) associated PNC with daily mortality and admissions, particularly for 
cardiovascular diseases lagged 1-day; increases in PNC (10,166 n/cm3) were associated 
with 2.2% (95% CI 0.6% to 3.8%) and 0.6% (0.4% to 1.7%) increases in cardiovascular 
deaths and admissions, respectively. Secondary pollutants, especially non-primary PM2.5, 
nitrate and sulphate, were more important for respiratory outcomes. 
Belleudi et al.48 (2010) considered the relationship between different PM fractions (PM10, 
PM2.5 and PNC) and admission to the hospital for various reasons. PNC showed an 
association only with admissions for heart failure (lag 0–5; 2.4% 0.2% to 4.7%) and COPD 
(lag 0; 1.6% 0.0% to 3.2%) for a 9,392 /cm3 increase in PNC. The effects were generally 
stronger in the elderly and during winter.  
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Forastiere et al.49 (2005) showed that air pollution on the day of death had the strongest 
effect on cardiovascular death (e.g., 7.6% increase [95% CI, 2.0–13.6%]) for an 
interquartile range of PNC, 27,790 particles/cm3.  
Halonen et al.50 (2008) assessed relationship between respiratory outcomes and 
particulate matter by size range, including nucleation (<0.03 µm), Aitken (0.03–0.1 µm) 
and accumulation (0.1–0.29 µm) mode particles. For the purpose of this study, the Aitken 
mode was considered as UFP (results showed higher significance than for nucleation 
mode). Observations were per IQR increase in particles (5760 /cm3). 
Halonen et al.51 (2009) considered association between hospital admissions for CVD and 
RD and particle number. They found that there was a suggestion of an association of 
hospital admissions for arrhythmia with Aitken mode particles and PM2.5 from traffic. 
Otherwise few associations were observed between various sizes and types of particles 
for either cardiovascular admissions or mortality. In contrast, most particle fractions had 
positive associations with admissions for pneumonia and asthma-chronic obstructive 
pulmonary disease (COPD). For the purpose of this review, the Aitken mode was 
considered as UFP (results showed higher significance than for nucleation mode). 
Observations were per IQR increase in Aitken mode particles (2467 /cm3). 
Ketunnen et al.52 (2007) evaluated the association between stroke and UFP. They found 
significant associations in the warm season, but not in the cold season. Percent changes 
in stroke were assessed per 7330 /cm3 increase in particle concentration. 
Lanki et al.53 (2006) found an association of the same day PNC levels with acute 
myocardial infarction (AMI). However, associations were only observed in the three cities 
with hospital discharge registers (v. general AMI registries) where power for city-specific 
analyses was higher. Effects of air pollution were more pronounced during the warm than 
the cold season. 
Stolzel et al.54 (2007) found statistically significant associations between elevated ultrafine 
particle (UFP; diameter: 0.01–0.1 µm) number concentration and total as well as cardio-
respiratory mortality, each with a 4 days lag. The relative mortality risk (RR) for a 9748 cm3 
increase in UFP NC was RR: 1.029 and its 95% CI 1.003–1.055 for total mortality. For 
cardio-respiratory mortality they found RR: 1.031, 95% CI: 1.003–1.060. This study is not 
included in Figures 9 and 10 because it did not consider CVD and RD separately. 
Von Klot et al.55 (2005) evaluated cardiac readmissions in association with PNC. They 
found that cardiac readmissions increased in association with same-day estimated PNC 
per 10000 particles/cm3. Pooled effect estimates for angina pectoris and myocardial 
infarction readmissions were comparable 
Chemical composition 
The analysis of the chemical composition in air monitoring data is relatively recent and 
there is not a large body of data accumulated yet for detailed analysis. 
Volcanic ash 
Volcanic ash can have high crystalline silica content, which is associated with silicosis, a 
scarring of lung tissue. Additionally, the particles can have high surface Fe2+ content, 
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which is associated with the formation of free radicals. Periods of high exposure to 
volcanic ash are typically not chronic.  
Acute respiratory symptoms (e.g., irritation) but no long term effects have been observed 
in the few (and rather small) studies conducted to date56. 
Wildfire smoke 
As with volcanic ash, most exposures to high levels of wildfire particulate are of an acute 
nature. Studies have shown significant increases in acute respiratory symptoms (e.g., 
asthma, rhinitis) and smaller but significant increases for more chronic respiratory 
diseases in vulnerable populations (i.e., bronchitis and COPD in certain age groups)57-59.  
Source apportionment studies 
Source apportionment studies use defined emissions profiles from various sources to 
identify the portion of ambient PM that can be attributed to these sources. The emission 
profiles can be defined a priori or using statistical analysis of the emission profiles. These 
studies link health effects to a source, not to a particular component of PM. Studies 
reviewed so far have considered outcomes such as cause-specific emergency room visits, 
non-accidental mortality, and changes in cardiac blood factors and sources such mobile 
source PM2.5, biomass combustion PM2.5, secondary sulphate PM2.5, and traffic speed 
changes60-62. 
6.3 Chemical composition of PM 
In chapter 5.1 it was reported that the analysis of the chemical composition in air 
monitoring data is relatively recent and there is not a large body of data accumulated yet 
for detailed analysis. On account of this, the literature search on chemical composition was 
intensified and a number of studies was found that allows even to perform statistical 
analysis in some cases. However, for most substances statistical analysis is inappropriate 
due to a lack of data. The search resulted in a total of 1660, 62-76 studies which provide RRs 
to almost 40 different substances. 
6.4 Evaluation of the Literature for PNC of UFP and precursor gases of secondary 
particles (SOx, NOx and CO) 
The literature review resulted in 28 studies45-55, 63, 65, 66, 77-89 providing information for PM10, 
PM2.5, PNC and (precursor gases of) secondary particles SOx, NOx and CO. Table A1 in 
the Annex provides single data points of the RR and the CI for PM10, PM2.5, PNC, SOx, 
NOx and CO. Table 4 summarizes the total number of data points read out from the 28 
studies for all different health endpoints. The blue fields indicate the total number of data 
points for a single substance (e.g. PNC vs. PNC=40 implies that 40 data points were found 
for PNC). Numbers in the right upper part of the blue fields indicate the number of data 
pairs for two substances (e.g. PM2.5 vs. PNC=29 implies that there are 29 paired data 
points for PNC and PM10 and paired means that both elements of the pair stem from the 
same study). In the left lower part the results for sample size from the power analysis are 
provided. Analysis of the mean values from PNC and PM2.5 with paired sample t-test 
contains 29 data points. Based on the mean values and the standard deviation for PNC 
